Richard Turkington

18.5k total citations · 1 hit paper
59 papers, 2.0k citations indexed

About

Richard Turkington is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Richard Turkington has authored 59 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Surgery, 25 papers in Oncology and 24 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Richard Turkington's work include Esophageal Cancer Research and Treatment (24 papers), Gastric Cancer Management and Outcomes (21 papers) and Pancreatic and Hepatic Oncology Research (11 papers). Richard Turkington is often cited by papers focused on Esophageal Cancer Research and Treatment (24 papers), Gastric Cancer Management and Outcomes (21 papers) and Pancreatic and Hepatic Oncology Research (11 papers). Richard Turkington collaborates with scholars based in United Kingdom, United States and Germany. Richard Turkington's co-authors include Helen G. Coleman, Andrew J. McGuigan, Paul Kelly, Claire Jones, Patrick G. Johnston, Sandra Van Schaeybroeck, Wendy L. Allen, Daniel B. Longley, Manuel Salto‐Tellez and Leanne Stevenson and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Richard Turkington

52 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes

2018 1.3k citations Andrew J. McGuigan, Richard Turkington et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard Turkington United Kingdom	16	1.2k	689	499	462	379	59	2.0k
George Van Buren United States	21	1.4k 1.2×	968 1.4×	583 1.2×	416 0.9×	321 0.8×	52	2.2k
Riccardo Giampieri Italy	26	1.3k 1.0×	687 1.0×	583 1.2×	256 0.6×	702 1.9×	122	2.2k
Atsushi Kudo Japan	28	1.0k 0.9×	725 1.1×	474 0.9×	566 1.2×	414 1.1×	129	2.4k
David Nathanson United States	24	901 0.7×	608 0.9×	411 0.8×	369 0.8×	213 0.6×	76	2.1k
Wungki Park United States	21	1.7k 1.4×	829 1.2×	654 1.3×	314 0.7×	803 2.1×	81	2.7k
Alexandra Drakaki United States	24	1.3k 1.1×	590 0.9×	425 0.9×	827 1.8×	623 1.6×	122	2.4k
Jianjun He China	27	837 0.7×	940 1.4×	846 1.7×	286 0.6×	433 1.1×	86	2.2k
Luca Faloppi Italy	25	807 0.7×	580 0.8×	601 1.2×	223 0.5×	499 1.3×	92	1.8k
Sara Bravaccini Italy	27	922 0.8×	806 1.2×	659 1.3×	215 0.5×	700 1.8×	125	2.1k
Aristidis Polyzos Greece	24	1.3k 1.1×	718 1.0×	366 0.7×	275 0.6×	481 1.3×	67	2.4k

Countries citing papers authored by Richard Turkington

Since Specialization

Citations

This map shows the geographic impact of Richard Turkington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Turkington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Turkington more than expected).

Fields of papers citing papers by Richard Turkington

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Turkington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Turkington. The network helps show where Richard Turkington may publish in the future.

Co-authorship network of co-authors of Richard Turkington

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Turkington. A scholar is included among the top collaborators of Richard Turkington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Turkington. Richard Turkington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smyth, Elizabeth, Daniel E. Griffiths, Kelly Cozens, et al.. (2024). 499TiP A single arm phase II trial of trastuzumab deruxtecan in patients with gastro-oesophageal adenocarcinoma cancer who are ctDNA and HER2 positive: DECIPHER (TRIALS IN PROGRESS). Annals of Oncology. 35. S199–S199.

Cobbe, Neville, et al.. (2024). The E3 ubiquitin ligase Itch regulates death receptor and cholesterol trafficking to affect TRAIL-mediated apoptosis. Cell Death and Disease. 15(1). 40–40. 13 indexed citations

Vikas, Praveen, Hans Messersmith, Carolyn C. Compton, et al.. (2023). Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists Guideline. Journal of Clinical Oncology. 41(10). 1943–1948. 57 indexed citations

Brown, Malcolm, Dominic O’Connor, Richard Turkington, et al.. (2023). Feasibility of delivering supervised exercise training following surgical resection and during adjuvant chemotherapy for pancreatic ductal adenocarcinoma (PRECISE): a case series. BMC Sports Science Medicine and Rehabilitation. 15(1). 116–116. 1 indexed citations

Stevenson, Leanne, Oliver Keminer, Björn Windshügel, et al.. (2022). Identification of Src as a Therapeutic Target in Oesophageal Adenocarcinoma through Functional Genomic and High-Throughput Drug Screening Approaches. Cancers. 14(15). 3726–3726. 3 indexed citations

McGuigan, Andrew J., et al.. (2021). The Role of Circulating Protein and Metabolite Biomarkers in the Development of Pancreatic Ductal Adenocarcinoma (PDAC): A Systematic Review and Meta-analysis. Cancer Epidemiology Biomarkers & Prevention. 31(5). 1090–1102. 2 indexed citations

Lavery, Anita, Leanne Stevenson, Andrew Walker, et al.. (2021). P-OGC08 Translational Insights from the Dual ErbB Inhibition in Oesophago-gastric Cancer (DEBIOC) Clinical Trial - A Bioinformatic Analysis. British journal of surgery. 108(Supplement_9). 1 indexed citations

Kunzmann, Andrew T., Helen G. Coleman, Brian T. Johnston, et al.. (2020). Does Risk of Progression from Barrett’s Esophagus to Esophageal Adenocarcinoma Change Based on the Number of Non-dysplastic Endoscopies?. Digestive Diseases and Sciences. 66(6). 1965–1973. 5 indexed citations

Kunzmann, Andrew T., Aaron P. Thrift, Brian T. Johnston, et al.. (2019). External validation of a model to determine risk of progression of Barrett’s oesophagus to neoplasia. Alimentary Pharmacology & Therapeutics. 49(10). 1274–1281. 17 indexed citations

10.

McManus, Damian, Stephen McQuaid, Jacqueline A. James, et al.. (2019). Alcohol intake, tobacco smoking, and esophageal adenocarcinoma survival: a molecular pathology epidemiology cohort study. Cancer Causes & Control. 31(1). 1–11. 19 indexed citations

11.

Bornschein, Jan, Lorenz Wernisch, Maria Secrier, et al.. (2019). Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction. International Journal of Cancer. 145(12). 3389–3401. 14 indexed citations

12.

Spence, Andrew D., Úna C. McMenamin, Richard Turkington, et al.. (2018). High PTGS2 expression in post‐neoadjuvant chemotherapy‐treated oesophageal adenocarcinoma is associated with improved survival: a population‐based cohort study. Histopathology. 74(4). 587–596. 3 indexed citations

13.

Turkington, Richard. (2015). Equal Protection of the Laws in Illinois. The De Paul law review. 25(2). 385.

14.

Allen, Wendy L., Richard Turkington, Leanne Stevenson, et al.. (2012). Pharmacogenomic Profiling and Pathway Analyses Identify MAPK-Dependent Migration as an Acute Response to SN38 in p53 Null and p53-Mutant Colorectal Cancer Cells. Molecular Cancer Therapeutics. 11(8). 1724–1734. 7 indexed citations

15.

Stevenson, Leanne, Wendy L. Allen, Richard Turkington, et al.. (2012). Identification of Galanin and Its Receptor GalR1 as Novel Determinants of Resistance to Chemotherapy and Potential Biomarkers in Colorectal Cancer. Clinical Cancer Research. 18(19). 5412–5426. 49 indexed citations

16.

Turkington, Richard. (2004). Protection for Invasions of Conversational and Communication Privacy by Electronic Surveillance in Family, Marriage, and Domestic Disputes Under Federal and State Wiretap and Store Communications Acts and the Common Law Privacy Intrusion Tort. Nebraska law review. 82(3). 4. 2 indexed citations

17.

Turkington, Richard & Anita L. Allen. (1999). Privacy law : cases and materials. 4 indexed citations

18.

Turkington, Richard. (1990). Legacy of the Warren and Brandeis Article: The Emerging Unencumbered Constitutional Right to Informational Privacy. Huskie Commons (Northern Illinois University). 16 indexed citations

19.

Turkington, Richard. (1987). Constitutional Limitations on Tort Reform: Have the State Courts Placed Insurmountable Obstacles in the Path of Legislative Responses to the Perceived Liability Insurance Crisis. Villanova law review. 32(6). 1299. 1 indexed citations

20.

Turkington, Richard. (1987). Legal Protection for the Confidentiality of Health Care Information in Pennsylvania: Patient and Client Recovery for Unauthorized Extra-Legal Disclosure. Villanova law review. 32(2). 259. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact